Steve Schonfeld’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding GLUE
BBA
Steve Schonfeld's GLUE Position: Q3 2026 in Review
Steve Schonfeld opened a new position in Monte Rosa Therapeutics (GLUE) in Q3 2026: 48,483 shares worth $578K. The stake represents ﹤0.01% of the portfolio and ranks #1900 among its holdings.
190 funds tracked by Wall St. Rank hold GLUE as of Q3 2026.
- Steve Schonfeld held 48,483 shares of Monte Rosa Therapeutics worth $578K as of Q3 2026.
- Monte Rosa Therapeutics was a new Steve Schonfeld position in Q3 2026.
- Monte Rosa Therapeutics made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1900 holding.
- 190 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q3 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.